Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Gross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Anteris Technologies Global (AVR) Shares Issued (2024 - 2025)

Anteris Technologies Global (AVR) reported Shares Issued of $25.2 million for Q4 2025, down 69.49% year-over-year from $82.6 million in Q4 2024, and up 4898.34% on a QoQ basis from $504167.0 in Q2 2025.

Anteris Technologies Global (AVR) has 2 years of Shares Issued data on file, last reported at $25.2 million in Q4 2025.

  • Quarterly Shares Issued fell 69.49% year-over-year to $25.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $25.8 million (down 78.42% YoY) and the FY2025 annual result came in at $25.8 million, down 78.42% from the prior year.
  • Shares Issued climbed to $25.2 million in Q4 2025 per AVR's latest filing, from $504167.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $82.6 million in Q4 2024 and bottomed at $114833.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 121.80 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 7.43 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 5.50 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 3.90 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 11.72 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 8.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 18.52 Mn
10 Anteris Technologies Global 753.31 Mn 753.28 Mn 380,000.00 -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 25.20 Mn
Dec 31, 2025 25.20 Mn
Jun 30, 2025 504,167.00
Jun 30, 2025 504,167.00
Mar 31, 2025 114,833.00
Mar 31, 2025 114,833.00
Dec 31, 2024 82.58 Mn
Dec 31, 2024 82.58 Mn
Sep 30, 2024 19.68 Mn
Sep 30, 2024 19.68 Mn
Jun 30, 2024 15.57 Mn
Jun 30, 2024 15.57 Mn
Mar 31, 2024 1.82 Mn
Mar 31, 2024 1.82 Mn